{"id":"https://openalex.org/W4310162912","doi":"https://doi.org/10.1182/blood-2022-166635","title":"Oral Realgar-Indigo Naturalis Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16","display_name":"Oral Realgar-Indigo Naturalis Formula Versus Intravenous Arsenic Trioxide for Non-High-Risk Patients with Acute Promyelocytic Leukemia: Interim Results of a Multicenter Randomized Controlled Trial APL16","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310162912","doi":"https://doi.org/10.1182/blood-2022-166635"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-166635","doi":"https://doi.org/10.1182/blood-2022-166635","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-166635","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100706686","display_name":"Huaiyu Wang","orcid":"https://orcid.org/0000-0002-6428-081X","observed_orcids":["https://orcid.org/0000-0002-6428-081X"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Huaiyu Wang","raw_affiliation_strings":["1The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shu Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shu Chen","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100457258","display_name":"Xiaojuan Zhang","orcid":"https://orcid.org/0000-0002-4441-0197","observed_orcids":["https://orcid.org/0000-0002-4441-0197"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xiaojuan Zhang","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057325735","display_name":"Xinhua Lu","orcid":"https://orcid.org/0000-0001-8132-8697","observed_orcids":["https://orcid.org/0000-0001-8132-8697"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xinhua Lu","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101470197","display_name":"Sha Gong","orcid":"https://orcid.org/0000-0001-7044-4668","observed_orcids":["https://orcid.org/0000-0001-7044-4668"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Sha Gong","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005791561","display_name":"David N. Wald","orcid":"https://orcid.org/0000-0002-8695-1178","observed_orcids":["https://orcid.org/0000-0002-8695-1178"]},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Wald","raw_affiliation_strings":["3Case Western Reserve University, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Case Western Reserve University, Cleveland, OH","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100454576","display_name":"Haitao Zhang","orcid":"https://orcid.org/0000-0001-6417-4622","observed_orcids":["https://orcid.org/0000-0001-6417-4622"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Haitao Zhang","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100337116","display_name":"Jing Li","orcid":"https://orcid.org/0000-0003-4038-3088","observed_orcids":["https://orcid.org/0000-0003-4038-3088"]},"institutions":[{"id":"https://openalex.org/I4210121771","display_name":"First Affiliated Hospital of Xi'an Jiaotong University","ror":"https://ror.org/02tbvhh96","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210121771"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Li","raw_affiliation_strings":["2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China","institution_ids":["https://openalex.org/I4210121771"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10924928,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"140","issue":"Supplement 1","first_page":"2014","last_page":"2015"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-promyelocytic-leukemia","display_name":"acute promyelocytic leukemia","score":0.9929999709129333},{"id":"https://openalex.org/keywords/arsenic-trioxide","display_name":"arsenic trioxide","score":0.8230000138282776},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.9810000061988831},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.7390000224113464},{"id":"https://openalex.org/keywords/traditional-chinese-medicine","display_name":"traditional Chinese medicine","score":0.7099999785423279},{"id":"https://openalex.org/keywords/home-based-treatment","display_name":"home-based therapy","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8069020509719849},{"id":"https://openalex.org/C2780386689","wikidata":"https://www.wikidata.org/wiki/Q7739","display_name":"Arsenic trioxide","level":3,"score":0.7301324009895325},{"id":"https://openalex.org/C2776601000","wikidata":"https://www.wikidata.org/wiki/Q612108","display_name":"Acute promyelocytic leukemia","level":4,"score":0.7093442678451538},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5511125326156616},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.5297796726226807},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5205448865890503},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4474305808544159},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.44325020909309387},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42441830039024353},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36060208082199097},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.1387937366962433},{"id":"https://openalex.org/C502230775","wikidata":"https://www.wikidata.org/wiki/Q871","display_name":"Arsenic","level":2,"score":0.10223349928855896},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.06772574782371521},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-166635","doi":"https://doi.org/10.1182/blood-2022-166635","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-166635","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2558328082","https://openalex.org/W4404149898","https://openalex.org/W3127033550","https://openalex.org/W4413782886","https://openalex.org/W2999156297","https://openalex.org/W2784807360","https://openalex.org/W2169503443","https://openalex.org/W3212984357","https://openalex.org/W2988780943","https://openalex.org/W4285614272"],"abstract_inverted_index":{"Background":[0],"Acute":[1],"promyelocytic":[2],"leukemia":[3,11],"(APL)":[4],"is":[5,61,109,132,180,207,331,560,615],"a":[6,57,164,287,642],"subtype":[7],"of":[8,29,76,91,150,250,280,302,318,328,334,338,342,345,390,443,486,522,548,556,558,578,591,596,621,634],"acute":[9,375],"myeloid":[10],"characterized":[12],"by":[13],"the":[14,72,127,148,303,316,369,444,472,476,491,519,657],"unique":[15],"chromosome":[16],"aberration":[17],"t":[18],"[(15;17)":[19],"(q22;":[20],"q21)].":[21],"APL":[22,99,226],"has":[23],"become":[24],"highly":[25],"curable":[26],"with":[27,80,216,223,239,659],"combination":[28,90,149],"all-trans":[30],"retinoic":[31],"acid":[32],"(ATRA)":[33],"and":[34,74,93,113,141,152,160,236,336,353,383,458,465,504,527,636,644],"arsenic":[35,64,161,211],"trioxide":[36,212],"(ATO).":[37],"However,":[38,107],"ATO":[39,153,256,270,606],"must":[40],"be":[41,629],"administered":[42],"intravenously.":[43],"Patients":[44,230,510],"need":[45],"long":[46],"hospital":[47],"stay":[48],"for":[49,98,213,315,490,607,647],"consolidation":[50,265,284,427,508,523,569,608],"therapy.":[51,428,509,524,553],"Realgar-indigo":[52],"naturalis":[53,205],"formula":[54,206],"(RIF),":[55],"as":[56],"traditional":[58],"Chinese":[59],"regimen,":[60],"an":[62,181],"oral":[63,203],"compound.":[65],"Previous":[66],"clinical":[67,187],"trials":[68,122],"in":[69,78,117,163,190,194,242,286,321,350,356,412,511,539,545,562,610,656],"China":[70],"proved":[71,594],"efficacy":[73,595],"safety":[75],"RIF":[77,92,108,424,599,640],"patients":[79,215,221,246,276,344,360,400,411,436,480,499,550],"APL.":[81,219,612,649],"(Hong-Hu":[82,101],"Zhu":[83,102],"et":[84,103],"al.":[85,104],"Lancet":[86],"Oncol":[87],"2018;871-879).":[88],"The":[89,298,312,325,429,449,532,554,613,652],"ATRA":[94,142,151,159,251,268,272,422,597,603,635,638],"created":[95],"homed-based":[96],"manner":[97],"treatment.":[100,487],"Blood":[105],"2019;597-605)":[106],"not":[110,416,469],"widely":[111],"used":[112],"still":[114],"only":[115],"available":[116],"China.":[118,195],"More":[119],"multicenter":[120],"controlled":[121],"are":[123],"needed":[124],"to":[125,134,170,200,209,263,367,395,404,506,602,631],"prove":[126],"efficacy.":[128],"In":[129],"addition,":[130],"it":[131,173],"inconvenient":[133],"administer":[135,633],"ATO/RIF":[136],"4-weeks":[137,139],"on":[138,144,166,289,624],"off":[140,168,291],"2-weeks":[143,145],"off.":[146],"Since":[147],"induces":[154],"synergistic":[155],"effects,":[156],"we":[157],"use":[158],"both":[162,512,540],"2-week":[165,167,288,290],"regimen":[169,292],"assess":[171],"if":[172],"will":[174],"improve":[175],"curative":[176],"effects.":[177],"Methods":[178],"APL16":[179],"open-label,":[182],"prospective,":[183],"multicenter,":[184],"noninferior,":[185],"randomized":[186,262],"trial":[188,199,330,653],"conducted":[189,197],"3":[191],"hematological":[192],"centers":[193],"We":[196],"this":[198,329,346,582,592],"evaluate":[201],"whether":[202],"realgar-indigo":[204],"noninferior":[208],"intravenous":[210,605],"non-high-risk":[214,648],"de":[217,224],"novo":[218,225],"Eligible":[220],"(n=81)":[222],"have":[227,481,529],"been":[228,530],"enrolled.":[229],"were":[231,261,361,401,468,537,583],"recruited":[232],"between":[233,471,585],"June":[234,243,357],"2016":[235,352],"April":[237],"2022,":[238],"final":[240,477],"follow-up":[241,489],"2022.":[244],"All":[245,275,497],"received":[247,277,421,438],"induction":[248,552],"therapy":[249,266,285,446,570,609],"60mg/day":[252],"(20-45":[253],"mg/m2/day)":[254],"plus":[255,269,273,423,598,604,639],"(0.15":[257],"mg/kg/day).":[258],"Then":[259],"they":[260],"receive":[264,417,507],"including":[267,363,452],"or":[271,282,407],"RIF.":[274],"6":[278,359],"cycles":[279],"ATRA/ATO":[281],"ATRA/RIF":[283],"after":[293,447,518],"achieving":[294],"molecular":[295,515],"complete":[296,502,516],"remission.":[297],"primary":[299],"end":[300],"point":[301],"study":[304,347,593],"was":[305,323,348,354,494,600,654],"event-free":[306],"survival":[307],"(EFS)":[308],"at":[309,439,461,534],"2":[310,535],"years.":[311],"noninferiority":[313],"margin":[314],"difference":[317,577],"two":[319,378,384,473,586],"arms":[320,513],"EFS":[322,533],"5%.":[324],"secondary":[326],"outcome":[327],"cumulative":[332],"incidence":[333,555],"relapses":[335,526,627],"quality":[337],"life.":[339],"Result":[340],"Enrollment":[341],"81":[343],"started":[349],"September":[351],"completed":[355,482],"2020.":[358],"excluded":[362],"one":[364,372,441],"who":[365,373,379,385,437],"refused":[366],"assign":[368],"informed":[370],"consent,":[371],"had":[374,380],"coronary":[376],"syndrome,":[377],"renal":[381],"insufficiency":[382],"died":[386],"before":[387],"genetic":[388],"diagnosis":[389],"PML-RARA":[391],"fusion":[392],"gene":[393],"due":[394],"intracranial":[396],"hemorrhage.":[397],"75":[398,435,498,549],"eligible":[399],"randomly":[402],"assigned":[403,418,445],"ATRA-ATO":[405,413,563],"group":[406,414,564,567,623],"ATRA-RIF":[408,566,622],"group.":[409],"Two":[410],"did":[415],"treatment":[419],"but":[420],"during":[425,551,568],"entire":[426],"modified":[430],"intention-to-treat":[431],"analysis":[432],"included":[433],"all":[434],"least":[440],"dose":[442],"randomisation.":[448],"baseline":[450],"characteristics":[451],"age,":[453],"sex,":[454],"white":[455],"blood":[456],"cell":[457],"platelet":[459],"counts":[460],"diagnosis,":[462],"Sanz":[463],"risk":[464],"PML":[466],"breakpoint":[467],"different":[470],"cohorts.":[474],"Until":[475],"follow-up,":[478],"68":[479],"their":[483],"planned":[484],"courses":[485],"Median":[488],"whole":[492],"cohort":[493],"24":[495],"months.":[496],"achieved":[500,514],"hematologic":[501],"remission":[503,517],"continued":[505],"second":[520],"cycle":[521],"No":[525,576,626],"deaths":[528],"observed.":[531],"years":[536],"100%":[538],"groups.":[541,587],"Differentiation":[542],"syndrome":[543],"occurred":[544],"nine":[546],"(12%)":[547],"decrease":[557],"fibrinogen":[559],"higher":[561],"than":[565],"(23.5%":[571],"vs":[572],"2.9%,":[573],"P=":[574],".032).":[575],"adverse":[579],"effects":[580],"except":[581,618],"observed":[584],"Conclusions:":[588],"Interim":[589],"results":[590],"non-inferior":[601],"standard-risk":[611],"toxicity":[614],"almost":[616],"equivalent":[617],"slightly":[619],"advantage":[620],"coagulation.":[625],"may":[628],"attributed":[630],"simultaneous":[632],"ATO/RIF.":[637],"offers":[641],"convenient":[643],"safe":[645],"alternative":[646],"Trial":[650],"registration:":[651],"registered":[655],"Register.ClinicalTrial.gov":[658],"NCT02899169.":[660],"Figure":[661],"1View":[662,665],"largeDownload":[663,666],"PPTFigure":[664],"PPT":[667],"Close":[668],"modal":[669]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2022-11-30T00:00:00"}